Fig. 2From: Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled studya Disease-free survival of the two treatment groups, b disease-free survival of the four subgroups, c overall survival of the two treatment groups, and d overall survival of the four subgroups in the intention-to-treat population. HR, hazard ratio; CI, confidence intervalBack to article page